Koons on Pfizer Agreeing to Buy Medivati...

Brad Smith, President of Microsoft, discusses updated content from his book "Tools and Weapons: The Promise and the Peril of the Digital Age." Jennifer Surane, Finance Reporter for Bloomberg News, talks about her story, "Wall Street Limps Into Post-Labor Day Return Derailed by De ... Show More

Phil Orlando, Chief Equity Market Strategist and Head of Client Portfolio Management at Federated Hermes, talks jobs and markets. Skylar Woodhouse, Reporter for Bloomberg News, discusses the aftermath of Hurricane Ida in New York City. Tom Bohn, President & CEO of the Association ... Show More

David Riley, Chief Investment Strategist at BlueBay Asset Management, previews jobs day. Rebecca Ray, Executive Vice President, Human Capital at The Conference Board, discusses their return to work study. Brian Fields, Groupon’s Chief Commercial Officer, talks trending stay-catio ... Show More

Bloomberg Intelligence Senior Transportation Analyst Lee Klaskow discusses Kansas City Southern considering Canadian National Railway's acquisition proposal. Bloomberg News Finance Reporter Max Abelson shares his story "A Day in the Life of Wall Street Shows NYC at Cusp of Comeba ... Show More

Laura Chico, Biotechnology Research Analyst at Wedbush Securities and Bloomberg News US Deals Team Leader Matthew Monks share their thoughts on the Bristol Myers acquisition Karuna Therapeutics. John Mowrey, CIO at NFJ Investment Group, explains where to find value in the markets ... Show More

Palantir lifted its 2025 revenue guidance and Pfizer has filed a second lawsuit against Novo Nordisk and obesity drug start-up Metsera. Plus, OpenAI inked a $38bn computing deal with Amazon, and the FT’s Claire Jones explains how the Trump administration is considering pushing fo ... Show More

Bloomberg’s Caroline Hyde and Ed Ludlow discuss Electronic Arts’ agreement to be sold in a record-breaking leveraged buyout. Plus, Huawei plans to ramp up production of its most advanced AI chips in a bid to take market share from Nvidia. And Peloton is preparing to launch new AI ... Show More

<p>(Bloomberg) -- Bloomberg Markets with Carol Massar and Cory Johnson. (Carol Solo)\u0010\u0010GUEST:\u0010Paul Sweeney\u0010Director:North American Research\u0010Bloomberg Intelligence\u0010Will discuss Discovery deal to buy Scripps Networks for $11.9 billion.</p><p>See <a href ... Show More

 Bloomberg News Health Reporter Madison Muller explains how Pfizer’s second weight-loss setback this year is a warning sign that breaking into the lucrative obesity market isn’t going to be easy. Cory Klippsten, CEO at Swan Bitcoin, shares his crypto outlook for 2024. Benjamin Wo ... Show More

Jennifer Rie, Bloomberg Intelligence Senior Litigation Analyst, and Nabila Ahmed, Bloomberg News Deals Reporter, discuss AT&T beating back another effort by the U.S. to undo its purchase of Time Warner, cementing an $85 billion deal to help it compete with Netflix. Stacey Boyd, C ... Show More

<p>Pharma stocks breaking out, as President Trump inks a drug pricing deal. What it means for the group, and how the broader health care sector is breathing a sigh of relief. Plus Elon Musk and some bingeing backlash. Why the billionaire is calling for customers to cancel their s ... Show More

Mankind Pharma has announced it will buy biotech company BSV for a whopping Rs 13,630 crore. The deal brings together a master of mass market products and an intrinsic innovator in the high entry barrier spaces of the healthcare market. It’s an expensive buy and Mankind has gone ... Show More